๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

โœ Scribed by Brinar, M.; Cleynen, I.; Coopmans, T.; Van Assche, G.; Rutgeerts, P.; Vermeire, S.


Book ID
118016722
Publisher
BMJ Publishing Group
Year
2010
Tongue
English
Weight
110 KB
Volume
59
Category
Article
ISSN
0017-5749

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Fecal S100A12 and fecal calprotectin as
โœ Marc A. Sidler; Steven T. Leach; Andrew S. Day ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB

## Background: Fecal calprotectin is a sensitive marker for gut inflammation. recently, we have established that a related protein, s100a12, is elevated in the feces of children with inflammatory bowel disease (ibd). this may represent a specific and sensitive disease marker. the objective was to i

Serum ฮฑ1-antitrypsin levels as a marker
โœ Dr. Michael J. Pettei; Jeremiah J. Levine ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB

The purpose of this study was to evaluate the use of the acute-phase serum protein a,-antitrypsin (a,- AT) compared with the erythrocyte sedimentation rate (ESR), platelet count, and hemoglobin level in screening for inflammation in newly diagnosed and known patients with inflammatory bowel disease